Hypertriglyceridemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients - GlobeNewswire (press release)



Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients 
GlobeNewswire (press release)
LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and ...

and more » 


Gemphire completes patient enrollment in INDIGO-1 trial in SHTG patients - Seeking Alpha



Gemphire completes patient enrollment in INDIGO-1 trial in SHTG patients 
Seeking Alpha
Gemphire Therapeutics (NASDAQ:GEMP) completes enrollment of 90 subjects in its Phase 2b INDIGO-1 trial investigating gemcabene in severe hypertriglyceridemia (SHTG) patients. Top-line results will be reported in Q2. The primary endpoint of the study is ...

and more » 


New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes - Medscape



Medscape
 
New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes 
Medscape
Pemafibrate (Kowa Company), a novel selective peroxisome proliferator-activated receptor alpha (PPAR?) modulator (or fibrate), may significantly improve lipid profiles and insulin resistance in patients with type 2 diabetes and hypertriglyceridemia ...

 


Amarin Announces Commencement of VASCEPAŽ Clinical Development in Mainland China - Markets Insider



Amarin Announces Commencement of VASCEPAŽ Clinical Development in Mainland China 
Markets Insider
BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics, today announced that a clinical trial of Vascepa ...
Amarin commences VASCEPA clinical development in China Seeking Alpha
Amarin (NASDAQ:AMRN) Rating Increased to Hold at Zacks Investment Research Dispatch Tribunal
Financial Newsletter - Zacks Investment Research Zacks Investment Research

all 23 news articles » 


Akcea Therapeutics (AKCA) Commences Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia ... - StreetInsider.com



MoneyMakingArticles
 
Akcea Therapeutics (AKCA) Commences Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia ... 
StreetInsider.com
Akcea Therapeutics, Inc. (NASDAQ: AKCA) today announced the initiation of a Phase 2b clinical study of AKCEA-APOCIII-LRx in patients with hypertriglyceridemia and established cardiovascular disease (CVD). The study will evaluate the safety and efficacy ...
Akcea Therapeutics launches mid-stage study of AKCEA-APOCIII-Lrx in patients with elevated triglycerides and CV ... Seeking Alpha
Financial Newsletter - Zacks Investment Research Zacks Investment Research

all 31 news articles » 


Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients Nasdaq ... - MENAFN.COM



Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients Nasdaq ... 
MENAFN.COM
LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and ...

 


Hypertriglyceridemia Market ? Report includes Industrial potential Growth with market share analysis and also ... - MilTech



Hypertriglyceridemia Market ? Report includes Industrial potential Growth with market share analysis and also ... 
MilTech
Hypertriglyceridemia Market report based on delivery model, application, services, and geography. A detailed analysis of the key industry players has been done to provide insights into their business, products and services, and key strategies such as ...

and more » 


Hypertriglyceridemia Market Report 2025 for Developing Business ... - Austrian Tribune



Hypertriglyceridemia Market Report 2025 for Developing Business ... 
Austrian Tribune
Hypertriglyceridemia - Market Insights, Epidemiology and Market Forecast ? 2025? report provides an overview of the disease and in depth research related to Hypertriglyceridemia for the 7MM (United States, Germany, France, Italy, Spain and UK) for the ...

and more » 


Hypertriglyceridemia Global Clinical Trials Review, H2, 2017 ... - satPRnews (press release)



Hypertriglyceridemia Global Clinical Trials Review, H2, 2017 ... 
satPRnews (press release)
The new report from Pharmaceuticals Market Reports has been published today. It provides updated in 2018 year analysis of Pharmaceutical Industries. Hypertriglyceridemia Global Clinical Trials Review, H2, 2017. Summary. The clinical trial report ...

and more » 


4 Signs Of Hypertriglyceridemia And How To Lower The Triglycerides Level - Health Thoroughfare



Health Thoroughfare
 
4 Signs Of Hypertriglyceridemia And How To Lower The Triglycerides Level 
Health Thoroughfare
Triglycerides, a type of fat that circulates in the blood, arise from the digestion process when the body experiences a surplus of calories. An increased number of triglycerides in the blood causes a number of conditions to occur: hypertriglyceridemia ...